Clinical Trials Directory

Trials / Completed

CompletedNCT05380297

Validation of acceXible's Automated Speech Analysis Method for the Early Detection and Monitoring of Patients With Mild Impairment or Dementia in Primary Care

Validación Del método de análisis Automatizado Del Habla "AcceXible" Para la detección Temprana y Seguimiento de Pacientes Con Deterioro Cognitivo Leve o Demencia en atención Primaria.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
273 (actual)
Sponsor
Accexible · Industry
Sex
All
Age
55 Years – 90 Years
Healthy volunteers
Accepted

Summary

Dementia, especially dementia caused by Alzheimer's disease, is considered one of the most severe health problems of our time. It is currently known that the disease begins many years before clinical symptoms appear. The sooner the patient is diagnosed, the sooner the patient will be in a position to prevent further deterioration. A recent orientation is the analysis of language in relation to the description of images with a high and varied semantic and emotional content. It can be studied that changes in the description of an image check if these changes are associated with the evolution of a person with probable impairment both in memory and cognitive as well as emotional, psychiatric, behavioral and even in their interaction with environmental factors especially those associated with socialization and loneliness. Thus, the purpose of this study is to validate speech analysis AI models.

Conditions

Interventions

TypeNameDescription
DEVICESpeech analysisSpeech analysis to detect and monitor mild cognitive impairment

Timeline

Start date
2021-05-17
Primary completion
2024-04-18
Completion
2024-04-18
First posted
2022-05-18
Last updated
2026-04-01

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT05380297. Inclusion in this directory is not an endorsement.